250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 5 Biotech VC Funds in Iceland

A list of 5 VC funds that invest in Biotech startups based in Iceland. We rank investors based on the number of investments they made in Biotech companies from Iceland. We update this investor list every month.

Top 5 Biotech VC Funds in Iceland

Investor Biotech Iceland investments
Brunnur Ventures 2
Kvika Asset Management 1
ABC Ventures 1
Flerie Invest 1
Silfurberg 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Brunnur Ventures VC Fund · Reykjavík, Gullbringusysla, Iceland · 3 investments in the past 12 months
Brunnur Ventures is a top venture capital firm in Iceland for startups with high-growth potential.
Show more
Investment focus
  • Software, SaaS, Biotechnology
  • Seed, Series A, Angel
  • Iceland, United States, Denmark
Portfolio highlights
  • PaxFlow — PaxFlow is a travel technology startup that helps tour operators to streamline operations with resource management, data based workflows, customer communication and self service tools.
  • Vitar Games — A WW1 Strategy driven Management Game
  • Standby Deposits — Standby Deposits is a rental security deposit replacement based on credit.
Kvika Asset Management VC Fund · Reykjavík, Gullbringusysla, Iceland
Kvika Asset Management manages a broad range of funds including equity funds, bond funds and mixed funds.
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Series A
  • Iceland
Portfolio highlights
  • EpiEndo Pharmaceuticals — Welcome to EpiEndo Pharma | Developing epithelial barrier enhancing drugs to treat chronic respiratory diseases
ABC Ventures VC Fund
ABC Ventures operates as an investment firm.
Show more
Investment focus
  • Water, Medical, Health Care
  • Pre-Seed, Series A
  • India, Iceland
Portfolio highlights
  • Polka Pop — Polka Pop is India's first brand to serve naturally flavored sparkling water with zero calories and no added sugar. Supporting a sustainable lifestyle choice, this healthy drink is available in four flavors, i.e. lemon-lime, orange, peach, and cranberry. The fizz makes this the best mix for cocktails and mocktails.
  • EpiEndo Pharmaceuticals — Welcome to EpiEndo Pharma | Developing epithelial barrier enhancing drugs to treat chronic respiratory diseases
Flerie Invest VC Fund
Flerie is an active long-term life science investor, focusing on biotech and pharmaceutical investments globally.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Funding Round, Series B
  • Sweden, Israel, Iceland
Portfolio highlights
  • AnaCardio — AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
  • Synerkine Pharma — Synerkine Pharma. Connecting Cytokines for the benefit of patients.
  • Vitara Biomedical — Vitara Biomedical has developed a therapeutic platform to support premature infants. Vitara Biomedical's platform was inspired by natural physiological processes to transform neonatal care.
Silfurberg VC Fund · Reykjavík, Gullbringusysla, Iceland
Silfurberg is an international venture capital firm that invests in early-stage health care, biotech, and other life science companies. The firm follows up its investments as an active participant in the company and aims all the time to add value to its investments whenever possible. Silfurberg was founded in 2002 and is based in Reykjavík,Iceland.
Show more
Investment focus
  • Health Care, Biotechnology, Pharmaceutical
  • Series A
  • Iceland
Portfolio highlights
  • Oculis — The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME(diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. Furthermore, the technique has been demonstrated to allow diseases at the anterior part of the eye to be treated with a reduced number of topical applications compared to conventional eye-drops.
Investors by industry
Investors by country
VC Funds in Iceland by industry